Peter Charles Goughnour

Title: The Innovations of Peter Charles Goughnour

Introduction

Peter Charles Goughnour is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. His innovative work has led to the development of a diagnostic composition that aids in the early detection of this prevalent disease.

Latest Patents

Goughnour holds a patent for a colorectal cancer diagnostic composition and method for detecting a diagnostic marker. This invention focuses on a composition that includes one or more mRNAs, specifically lysyl-tRNA synthetase (KRS) and aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1 (AIMP1). The method involves measuring the protein expression levels of these markers from a sample obtained from a test subject. The invention provides crucial information necessary for diagnosing colorectal cancer, as it identifies raised expression levels of KRS and AIMP1 in the serum of colorectal cancer patients compared to a normal control group.

Career Highlights

Goughnour is affiliated with the Medicinal Bioconvergence Research Center, where he continues to advance his research and innovations. His work is pivotal in enhancing diagnostic methods, which can lead to more effective treatment options for patients suffering from colorectal cancer.

Collaborations

Goughnour collaborates with esteemed colleagues such as Sunghoon Kim and Min Chul Park. Their combined expertise contributes to the ongoing research and development of innovative medical solutions.

Conclusion

Peter Charles Goughnour's contributions to colorectal cancer diagnostics exemplify the impact of innovation in medicine. His work not only enhances diagnostic accuracy but also plays a crucial role in improving patient outcomes.